Community pharmacists play an important role in the provision of health promotion services, and community pharmacies are considered as a potentially ideal site for cardiovascular health promotion. Information based on a systematic review of barriers to promoting cardiovascular health in community pharmacy is currently lacking. We have sought to identify the most important barriers to cardiovascular health promotion in the community pharmacy. We have systematically searched PubMed and International Pharmaceutical Abstracts for a period of 15 years from 1 April 1998 to 1 April 2013, contacted subject experts and hand-searched bibliographies. We have included peer-reviewed articles, with English abstracts in the analysis, if they reported community pharmacists' perceptions of the barriers to cardiovascular health promotion activities in a community pharmacy setting. Two reviewers have independently extracted study characteristics and data. We identified 24 studies that satisfy the eligibility criteria. The main barriers to cardiovascular health promotion in the community pharmacy included pharmacist-related factors; practice site factors; financial factors; legal factors; and patient-related factors. This review will help to provide reliable evidence for health promotion practitioners of the barriers to promoting cardiovascular health in the community pharmacy setting. This knowledge is valuable for the improvement of cardiovascular health promotion in this setting and guiding future research.
of global disability-adjusted life years (Murray et al. 2012) . CVD reduces productivity, curtails economic growth and poses a significant social challenge in high-, middle-and lowincome countries (Alwan et al., 2011b; Heidenreich et al., 2011; Mendis et al., 2011) . Fortunately, CVD is largely preventable through modest investments in primary prevention interventions focused on reducing major behavioural risk factors such as tobacco use, harmful use of alcohol, unhealthy diet or physical inactivity (Alwan et al., 2011a) .
The growing threat posed by CVD requires a more forceful response. These data should impel public health professionals to seek new solutions, even more effective than before. At this point, professionals in health promotion, education and counselling can play a strong leadership role, from the discovery to the delivery of effective cardiovascular health promotion (Catford, 2009) .
According to the American Heart Association, the cornerstone of primary prevention of CVD is the adoption of healthy life habits, including the avoidance of tobacco (including second-hand smoke), healthy dietary patterns, weight control and regular, appropriate physical activity (Pearson et al., 2002 (Pearson et al., , 2003 (Pearson et al., , 2013 . These public health recommendations should be supported and reinforced, for all patients, by all healthcare providers.
Community pharmacists are recognized as highly trained and accessible healthcare professionals and they are expected to play an increasing role in promoting healthy behaviour , with the potential to complement alternative mechanisms for promoting cardiovascular health, such as television advertising, use of social media, health professionals in other retail outlets, extending the roles of nutritionists and personal trainers or having pharmacists in general practitioners's surgeries. The significant potential role of community pharmacists in CVD prevention, through cardiovascular health promotion services, is increasingly being investigated (Maguire et al., 2001; Hourihan et al., 2003; Mangum et al., 2003; Sinclair et al., 2004; Clifford et al., 2005; Hersberger et al., 2006; Snella et al., 2006; Krass et al., 2007; Dent et al., 2009; Katoue et al., 2013; Um et al., 2013) .
Although more evidence from randomized trials evaluating effectiveness and cost-effectiveness is needed, the community pharmacy setting has been proposed as a potential prime location to develop promotion activities (Anderson, 2000; Edmunds and Calnan, 2001; Chandra et al., 2003; Lloyd-Williams, 2003; Björkman et al. 2008; Carter et al., 2009) . Also, there is growing research recommending health promotion pharmacy practice (Hourihan et al., 2003; Dhital et al., 2010) . However, several studies worldwide have warned of some barriers that could jeopardize the promising contribution of community pharmacists to cardiovascular health promotion. Awareness of these barriers may be the first step to overcoming them. To date, there has been no systematic review of published literature available on this topic. Therefore, to identify the main obstacles hampering the development of cardiovascular health promotion activities by community pharmacies or limiting community pharmacists' involvement in the provision of cardiovascular health promotion and preventive services, we have reviewed published cross-sectional studies in which pharmacists' perceptions of the barriers to providing cardiovascular health promotion services were reported.
METHODS

Data sources
For the purposes of this paper, cardiovascular health promotion refers to the process of enabling people to increase control over, and to improve, their cardiovascular health (World Health Organization, 1986) , including health promotion activities related to these topics: high blood pressure, overweight or obesity, dyslipidaemia, metabolic syndrome, smoking, diabetes, diet and physical activity.
The search was conducted, as far as possible, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2009) . Although the PRISMA statement focuses mainly on randomized trials, it is also recognized as a useful tool for reporting systematic reviews of other types of research (Moher et al., 2009) .
To identify potentially relevant studies, we carried out a systematic search in the following electronic databases: International Pharmaceutical Abstracts (IPAs) and MEDLINE database through PubMed web-based retrieval system developed by the National Centre for Biotechnology Information at the U.S. National Library of Medicine, for the period between 1 April 1998 and 1 April 2013. A set of Boolean searches were conducted using the following text terms in combination: community pharmacy, pharmacist, cross-sectional, survey, questionnaire, barrier and barriers, in the title or abstract. Truncation symbols were used with the terms community pharmacy (community pharmac*) and pharmacist ( pharmacist*) to retrieve all variants of these word stems. An information professional supervised the search process. Only English-language studies were included. We also used the web search engine Google Scholar to perform an additional and complementary search for papers citing the oldest reference detected in both IPA and MEDLINE search and potentially included in the review. Duplicated references were detected using RefWorks © (www.refworks.com). All titles and abstracts were screened by two of the authors. If the title and abstract indicated that the study fulfilled the eligibility criteria (based on inclusion and exclusion criteria) or neither the title nor the abstract provided sufficient information for selection decision, both reviewers evaluated the full texts of articles for eligibility. Furthermore, the reference lists of all the studies included were checked for any further relevant paper not identified in the previous search. All full-text papers were obtained either from journal archives or directly from the authors. To minimize bias and ensure that the findings are reproducible, both reviewers independently selected studies based on full texts; any disagreements were resolved by discussion with reference to the research objective until consensus was reached. Cohen's kappa-statistic (κ) was calculated to measure the agreement between the two reviewers (Cohen, 1960) using Stata/IC 12.0 (StataCorp, 2011).
Inclusion and exclusion criteria
The following inclusion criteria had to be fulfilled: (i) English-language publications; (ii) a cross-sectional (or survey) study design; (iii) reporting of community pharmacists perceptions and (iv) data on barriers to cardiovascular health promotion in a community pharmacy setting. Excluded were studies that failed to report sufficient quantitative data to establish an order of importance among the barriers reported by community pharmacists.
Data extraction
Data were extracted independently and in duplicate by the two reviewers. For each study, the following characteristics were extracted: names of authors; location of study; time of study ( publication date); characteristics of pharmacists: age distribution (mean, standard deviation, range), gender (% women), and position; response rate and final sample size; cardiovascular health promotion activities evaluated in the study; main reported barrier to cardiovascular health promotion activities and percentage of participants who reported the main identified barrier.
Quality assessment
Since there is no strong consensus as to the best standardized method for assessing the quality of cross-sectional studies, the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline was used as a proxy measure for quality (von Elm et al., 2007) . This guideline was not developed specifically as a tool for assessing the quality of published observational research but for its appropriate reporting. It includes 22 items that relate to the article's title and abstract (item 1), the introduction (items 2 and 3), methods (items 4-12), results (items 13-17), discussion sections (items 18-21) and funding information (item 22). For all studies, each item was graded 1 (appropriately reported) or 0 (not appropriately reported or unclear).
Data synthesis
Data are presented as frequency distribution of studies reporting each identified barrier. The quality and heterogeneity of the available data meant that we could not undertake a formal meta-analysis of the reported numerical results.
RESULTS
The electronic databases and web search engine searches identified 808 references. After removing duplicate references (those retrieved by both database and web search engine searches) and screening titles and abstracts, 49 references remained for full-text review. As shown in Figure 1 , 22 articles met the eligibility criteria, whereas 27 references were excluded (their study design was not cross-sectional or survey-based, n = 14; they did not report community pharmacists perceptions or data on barriers to cardiovascular health promotion in a community pharmacy setting, n = 12 were not included). Screening reference lists and citations of included articles resulted in two additional articles that met the eligibility criteria. Therefore, 24 studies were included in this systematic review. The κ value for agreement between the two reviewers was 0.96 (p value <0.001); this result lies in the range (κ = 0.81-1.00) for almost perfect agreement (Landis and Koch, 1977) . Table 1 shows the characteristics of the 24 studies included in this review. From the searches undertaken between April 1998 and April 2013, the studies selected in this review were published from 1999 to 2013 with four articles in 2012; three articles in 2000, 2006, 2010 and 2011; two articles in 2007; and one article in 1999, 2002, 2003, 2008, 2009 and 2013 . Eight studies were conducted in the United States of America (Couchenour et al., 2000; Kotecki et al., 2000; Williams et al., 2000; Margolis et al., 2002; Aquilino et al., 2003; Hudmon et al., 2006; O'Donnell et al., 2006; Dent et al., 2010) , three in Australia (Edwards et al., 2006; Berbatis et al., 2007; Wibowo et al., 2010) , two in Canada (O'Loughlin et al., 1999; Laliberté et al., 2012) , two in Kuwait (Awad and Abahussain 2010; Awad and Waheedi, 2012) , two in New Zealand (Sheridan et al., 2008; Tordoff et al., 2012) , one in China (Fang et al., 2011) , one in Malaysia (Hassali et al., 2009) , one in Qatar (El Hajj et al., 2012) , one in Scotland (Newlands et al., 2011) , one in Sudan (Mohamed et al., 2013) , one in Thailand (Thananithisak et al., 2008) and one in the United Arab Emirates (Hasan et al., 2011) . According to the scope of this review, all studies had a cross-sectional survey design that targeted community pharmacists' perceptions of barriers to promoting cardiovascular health in the community pharmacy. The response rate ranged between 11.7% (Margolis et al., 2002) and 93.6% (Awad and Waheedi, 2012) . The participants were predominantly women (>50%) in 5 of the 24 studies (Sheridan et al., 2008; Fang et al., 2011; Newlands et al., 2011; Laliberté et al., 2012; Mohamed et al., 2013) . Three studies did not report data on the gender of the participants, and 7 of the 24 studies did not provide information on the participant's age (Table 1) . The most frequent cardiovascular risk factor targeted by health promotion activities or services reported in the studies was tobacco use (17 studies), followed by hypertension (high blood pressure) (10 studies), high blood glucose (diabetes) (9 studies), unhealthy diet (7 studies), cholesterol or lipids (6 studies), and physical inactivity (4 studies). Figure 2 shows study quality assessment.
The principal barriers to cardiovascular health promotion in the community pharmacy reported by pharmacists according to the studies included in this review were: lack of time or time constraints (reported as the main barrier in 10 of the 24 studies), lack of patient awareness about pharmacists' expertize in counselling or lack of patient demand (the main barrier in two studies), low confidence to ask about smoking when unrelated to the presenting condition (one study), lack of physical space for pharmaceutical care provision (one study), lack of awareness when products for cardiovascular risk factor cessation were being purchased (one study), constraints while working (one study), difficulty to get people to avoid CVD risk behaviour (one study), lack of training, skills or instrumentation (two studies), lack of contract or remuneration (one study), workload increase (one study), lack of recognition by other healthcare professionals (one study), lack of the concept of teamwork with other healthcare professionals (one study) and other interpersonal characteristics (e.g. feeling uncomfortable asking patients about their CVD risk factors; one study) ( Table 1) .
Other barriers and frequency of studies are listed in Table 2 . These have been classified in six categories: pharmacist-related factors, practice site factors, financial factors, legal and regulatory factors, patient-related factors and other factors. The highest frequency of studies corresponded to the barrier of lack of time (95.8%).
DISCUSSION
This systematic review synthesizes, for the first time, evidence-based information on key barriers to providing cardiovascular health promotion services in the community pharmacy extracted from studies reporting pharmacists' views on this issue. All studies included in this review are cross-sectional surveys. This type of design is a valuable method in assessing practice, attitudes, knowledge and beliefs of a population in relation to a particular health-related event.
According to the frequency of the main barriers reported by the studies included in this review, lack of time may be considered the most important obstacle confronting cardiovascular health promotion in the community pharmacy. Furthermore, lack of time is the barrier reported in most of the studies included. Lack of sufficient time has been identified as the main impediment to developing other relevant non-communicable diseases health promotion activities in the community pharmacy, such as those activities related to cancer health promotion services in this setting (Beshir and Hanipah, 2012) . Consistently, qualitative research in different locations has identified lack of time as a major problem for pharmacists in providing cardiovascular health promotion activities or services (Anderson, 2000; Björkman et al. 2008; Eades et al., 2011) .
It has been suggested that the availability of time for pharmaceutical care and health promotion activities in the community pharmacy may be expanded by better delineation of the roles of licensed pharmacists and other professionals working in the community pharmacy setting (such as pharmacy technicians) (Anderson, 2000; Awad and Waheedi, 2012) , which could be applied to the specific cardiovascular health promotion services. Thus, pharmacists should be more involved in patient-focused care, such as counselling activities, and less in administrative duties. The reasons behind the lack of time as a recurring barrier deserves further exploration as it may actually mask other barriers such as lack of motivation, lack of personnel, increase in pharmacists' workload or lack of prioritization of the health promotion intervention. Lack of time may also be influenced by limited financial reward to be gained from spending time on cardiovascular health promotion activities. Future research evaluating the relation between these factors may be warranted.
Another important barrier reported by pharmacists is the lack of patient demand for cardiovascular health promotion activities. Lack of demand should be interpreted in the light of any marketing that has been done to promote the service since an effective marketing strategy may be the answer to increasing patient awareness. However, the studies did not report enough information on this issue. Low patient demand for, and the lack of patient awareness of pharmacists' expertize on, cardiovascular health promotion service in the community pharmacy could be overcome by following proactively the first three A's of the 5 A's model for treating tobacco use and dependence (Ask about tobacco use, Advice on quitting, Assess willingness to make an attempt at quitting, Assist in attempts to quit, Arrange follow-up) (Fiore et al., 2008) . This screening may be adapted for other cardiovascular risk factors, such as has been suggested in other healthcare settings for obesity (Jay et al., 2010; Alexander et al., 2011; Vallis et al., 2013) or physical inactivity (Carroll et al., 2011) .
Low confidence to ask about a particular cardiovascular risk factor when unrelated to the presenting condition, the difficulty in getting people to abandon a cardiovascular risk behaviour, and the lack of skills or training are relevant barriers that restrict the potential of community pharmacists in cardiovascular health promotion. These obstacles may be remedied through accredited training in health promotion knowledge and skills, with on-going support for the health promotion role, as has been proved effective with programmes developed in the United Kingdom (Anderson, 2000) .
One study reported, as a principal barrier, the inability to identify patients who could specially benefit from cardiovascular health promotion. One possible solution may be to incorporate an alert, in the dispensing software, that reminds and prompts the community pharmacist to provide the cardiovascular health promotion service (counselling, etc.) . This measure has been effective for other healthcare providers (Dexheimer et al., 2008) .
These findings should be interpreted in the context of several limitations. A key source of potential bias in this review is bias due to limitations in the original studies contained therein. Data from studies included in this review are based on a form of self-assessment reporting. Although there is always some potential for bias or inaccuracy in self-assessment reports, particularly if the questions concern personal or controversial issues, research has shown that self-assessment reporting measures are generally valid. In any case, self-assessment reporting is more than likely the only way to obtain information on community pharmacists' perceptions and views.
The findings in this review may also be limited in their generalizability. The unsatisfactory response rate in some of the studies included may lead to a lack of representativeness of the target population and biased results, because nonrespondents may have reported different views. Moreover, data on the cross-sectional studies included represent pharmacists' perceptions at a particular point in time, in particular populations, and thus do not reflect changes over time or the perceptions of other possible target populations of community pharmacists, which may be influenced by other factors, such as different healthcare systems or organizational contexts (e.g. we noticed a lack of European studies that fulfilled the eligibility criteria).
CONCLUSION
Despite the fact that the community pharmacy setting is recognized as an excellent opportunity to develop activities to promote cardiovascular health, studies have documented various barriers to the proper implementation of these health promotion services. The purpose of this study was to identify the factors that pharmacists perceive as barriers to performing cardiovascular health promotion activities. These results pose the challenge to overcome the barriers identified in this study and turn them into opportunities to build on the potential of community pharmacists to promote cardiovascular health and prevent disease.
Based on this review, two relevant gaps in the literature have been identified that need to be addressed. First, there is a lack of data from other geographical settings, such as southern European regions, on community pharmacists' perceptions of barriers to specifically conducting cardiovascular health promotion in community pharmacies. Secondly, a proper interpretation of these barriers may be facilitated if future research includes more detailed information on the nature and intensity of the cardiovascular health promotion activities or services (for example, data on pharmacists' skill, training, time and resources, marketing or promotion of the activity or service, and facilities to deliver the service, such as private counselling areas). A meaningful interpretation of these barriers is necessary in order to develop and investigate effective intervention strategies to help and encourage community pharmacists to overcome obstacles that hinder the proper dispensation of cardiovascular health promotion services.
PRACTICAL IMPLICATIONS
These findings will help health promotion practitioners to identify the most important barriers to carrying out cardiovascular health promotion activities in the community pharmacy. Prior to face these barriers, policy makers should take into account the current need of more costeffectiveness evidence of cardiovascular health promotion services in community pharmacies. This study also provides an evidence-based foundation from which to design and evaluate future strategies to improve health promotion services in the community pharmacy.
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